CYBEROPTICS CORP

2020 Q1 Form 10-Q Financial Statement

#000089710120000335 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.66M $17.00M
YoY Change -19.65% 30.57%
Cash & Equivalents $6.069M $9.315M
Short-Term Investments $7.590M $7.680M
Other Short-Term Assets $1.060M $1.652M
YoY Change -35.84% -10.31%
Inventory $17.05M $17.58M
Prepaid Expenses $569.0K
Receivables $14.33M $13.04M
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.67M $49.27M
YoY Change -5.28% 18.31%
LONG-TERM ASSETS
Property, Plant & Equipment $3.063M $3.362M
YoY Change -8.89% 46.68%
Goodwill $1.366M $1.366M
YoY Change 0.0% 0.0%
Intangibles $280.0K $324.0K
YoY Change -13.58% -7.95%
Long-Term Investments $15.19M $8.690M
YoY Change 74.8% -12.31%
Other Assets $4.890M $252.0K
YoY Change 1840.48% -4.55%
Total Long-Term Assets $28.51M $21.66M
YoY Change 31.63% 7.54%
TOTAL ASSETS
Total Short-Term Assets $46.67M $49.27M
Total Long-Term Assets $28.51M $21.66M
Total Assets $75.18M $70.93M
YoY Change 5.99% 14.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.192M $6.180M
YoY Change 32.56% 4.83%
Accrued Expenses $2.559M $2.643M
YoY Change -3.18% 12.9%
Deferred Revenue $548.0K $843.0K
YoY Change -34.99%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.04M $9.920M
YoY Change 21.32% 11.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $204.0K $103.0K
YoY Change 98.06% -51.18%
Total Long-Term Liabilities $204.0K $103.0K
YoY Change 98.06% -51.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.04M $9.920M
Total Long-Term Liabilities $204.0K $103.0K
Total Liabilities $16.15M $13.76M
YoY Change 17.37% 48.45%
SHAREHOLDERS EQUITY
Retained Earnings $23.92M $22.79M
YoY Change 4.93% 18.31%
Common Stock $37.02M $35.94M
YoY Change 2.99% 4.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.04M $57.18M
YoY Change
Total Liabilities & Shareholders Equity $75.18M $70.93M
YoY Change 5.99% 14.8%

Cashflow Statement

Concept 2020 Q1 2019 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
7950000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
7283000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
7026000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2395000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
664000 USD
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17000 USD
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
CYBEROPTICS CORP
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000768411
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0 USD
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity File Number
EntityFileNumber
0-16577
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1472057
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5900 Golden Hills Drive
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
MINNEAPOLIS
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
CY2020Q1 dei City Area Code
CityAreaCode
(763)
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
542-5000
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2020Q1 dei Trading Symbol
TradingSymbol
CYBE 
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6069000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5836000 USD
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7593000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8295000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
299000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
322000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14327000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16059000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
17050000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
15580000 USD
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
569000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
559000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1060000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1020000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
46668000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
47349000 USD
CY2020Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
15187000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3063000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
280000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
310000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1366000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1366000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2850000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2111000 USD
CY2020Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
876000 USD
CY2019Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
962000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4892000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4992000 USD
CY2020Q1 us-gaap Assets
Assets
75182000 USD
CY2019Q4 us-gaap Assets
Assets
72599000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8192000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7023000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
548000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
499000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2559000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2572000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
736000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
688000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12035000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10782000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
204000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
202000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3758000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3141000 USD
CY2020Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
150000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
150000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
16147000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
14275000 USD
CY2020Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7164654 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7164654 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7154591 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7154591 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
37016000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
36659000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1896000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23915000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23071000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
59035000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
58324000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75182000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72599000 USD
CY2020Q1 us-gaap Revenues
Revenues
16429000 USD
CY2019Q1 us-gaap Revenues
Revenues
14976000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
9146000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2293000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4159000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4163000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
570000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
264000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
59000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
993000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
629000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
844000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
495000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7157000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7100000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7367000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7322000 shares
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
495000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
87000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
140000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
58000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-460000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
145000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
30000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
12000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-490000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
133000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
354000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
628000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
844000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
495000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
663000 USD
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
137000 USD
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
236000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-23000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-44000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
64000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
71000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
381000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-70000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
272000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
244000 USD
CY2020Q1 us-gaap Available For Sale Equity Securities Gross Unrealized Loss
AvailableForSaleEquitySecuritiesGrossUnrealizedLoss
18000 USD
CY2019Q1 us-gaap Available For Sale Equity Securities Gross Unrealized Loss
AvailableForSaleEquitySecuritiesGrossUnrealizedLoss
1000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1841000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2866000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2086000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1625000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
111000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3205000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7157000 shares
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1348000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2353000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
51000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
207000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-802000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-200000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-34000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2452000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
440000 USD
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3106000 USD
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1052000 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
5294000 USD
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1263000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
129000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
183000 USD
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2334000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
85000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
30000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
233000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
67000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5836000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6069000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9315000 USD
CY2020Q1 us-gaap Revenues
Revenues
16429000 USD
CY2020Q1 cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1 pure
CY2019Q1 cybe Percentage Of Revenue Performance Obligations
PercentageOfRevenuePerformanceObligations
1 pure
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
27000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2000 USD
CY2020Q1 cybe Contract With Customer Liability Advance Customer Payments
ContractWithCustomerLiabilityAdvanceCustomerPayments
406000 USD
CY2019Q4 cybe Contract With Customer Liability Advance Customer Payments
ContractWithCustomerLiabilityAdvanceCustomerPayments
389000 USD
CY2020Q1 cybe Contract With Customer Liability Deferred Warranty Revenue
ContractWithCustomerLiabilityDeferredWarrantyRevenue
309000 USD
CY2019Q4 cybe Contract With Customer Liability Deferred Warranty Revenue
ContractWithCustomerLiabilityDeferredWarrantyRevenue
275000 USD
CY2019Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
76000 USD
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
30000 USD
CY2020Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
100000 USD
CY2019Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
114000 USD
CY2020Q1 cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
176000 USD
CY2019Q1 cybe Contract With Customer Liability And Deferred Revenue Revenue Recognized
ContractWithCustomerLiabilityAndDeferredRevenueRevenueRecognized
144000 USD
CY2020Q1 cybe Maximum Maturity Of Debt Securities
MaximumMaturityOfDebtSecurities
P5Y
CY2020Q1 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
224000 USD
CY2019Q4 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
84000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
3185000 USD
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
18000 USD
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
833000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q1 cybe Marketable Securities Classified As Cash Equivalents Cost
MarketableSecuritiesClassifiedAsCashEquivalentsCost
2000000.0 USD
CY2019Q4 cybe Marketable Securities Classified As Cash Equivalents Cost
MarketableSecuritiesClassifiedAsCashEquivalentsCost
2600000 USD
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2020Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2020Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
22780000 USD
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
20463000 USD
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q1 cybe Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
3 stock-based_complensation_plan
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
520513 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.25
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10063 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.44
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
510450 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.33
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
370876 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.39
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1100000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
45000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
43000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
68204 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
17.26
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
66204 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.39
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
272000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
244000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2100000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M14D
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
58324000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
85000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
272000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-490000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
59035000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
56211000 USD
CY2019Q1 cybe Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Units Net Of Shares Exchanged As Payment
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedUnitsNetOfSharesExchangedAsPayment
59000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
244000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
133000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
57175000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
10556000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9845000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2055000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1837000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3055000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2373000 USD
CY2020Q1 us-gaap Other Inventory Demo
OtherInventoryDemo
1384000 USD
CY2019Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
1525000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
15580000 USD
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
656000 USD
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
649000 USD
CY2020Q1 cybe Demonstration Inventory Useful Life
DemonstrationInventoryUsefulLife
P36M
CY2020Q1 cybe Accumulated Amortization Inventories
AccumulatedAmortizationInventories
2400000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1487000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1319000 USD
CY2020Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
748000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
761000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
219000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
333000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
159000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2559000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2572000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
798000 USD
CY2020Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
230000 USD
CY2019Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
174000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
17000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
244000 USD
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
785000 USD
CY2019Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
826000 USD
CY2020Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
748000 USD
CY2019Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
795000 USD
CY2020Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
37000 USD
CY2019Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
31000 USD
CY2018Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
218000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
134000 USD
CY2019Q1 us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
87000 USD
CY2020Q1 cybe Extended Product Warranty Accrual Amortization Of Deferred Revenue
ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue
100000 USD
CY2019Q1 cybe Extended Product Warranty Accrual Amortization Of Deferred Revenue
ExtendedProductWarrantyAccrualAmortizationOfDeferredRevenue
114000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
309000 USD
CY2019Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
191000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
227000 USD
CY2019Q1 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
186000 USD
CY2019Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
275000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
82000 USD
CY2019Q1 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
5000 USD
CY2020Q1 cybe Order Backlog Yet To Be Recognized As Revenue
OrderBacklogYetToBeRecognizedAsRevenue
24800000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3223000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2943000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
280000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
310000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
126000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
100000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
43000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2000 USD
CY2020Q1 us-gaap Revenues
Revenues
16429000 USD
CY2020Q1 cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.72 pure
CY2019Q1 cybe Revenue Export Sales Percentage
RevenueExportSalesPercentage
0.71 pure
CY2020Q1 cybe Export Revenues
ExportRevenues
11780000 USD
CY2019Q1 cybe Export Revenues
ExportRevenues
10605000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
844000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
210000 shares
CY2020Q1 cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
-0.01
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
844000 USD
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7367000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
495000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7100000 shares
CY2019Q1 cybe Earnings Per Share Dilutive Adjustment
EarningsPerShareDilutiveAdjustment
0
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
495000 USD
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7322000 shares
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
145000 shares
CY2020Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0 USD
CY2020Q1 cybe Need For Valuation Allowance Based On History Of Cumulative Losses
NeedForValuationAllowanceBasedOnHistoryOfCumulativeLosses
P3Y
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-600000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-600000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
87000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
87000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
140000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
30000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
110000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
12000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
46000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-460000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
30000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-490000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
145000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
12000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
133000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1406000 USD
CY2020Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-490000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1690000 USD
CY2019Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
133000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1557000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.15 pure
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
952000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
961000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
977000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
778000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
662000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
909000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5239000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
745000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4494000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M29D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0518 pure
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000.0 USD

Files In Submission

Name View Source Status
0000897101-20-000335-index-headers.html Edgar Link pending
0000897101-20-000335-index.html Edgar Link pending
0000897101-20-000335.txt Edgar Link pending
0000897101-20-000335-xbrl.zip Edgar Link pending
cybe-20200331.htm Edgar Link pending
cybe-20200331.xsd Edgar Link pending
cybe-20200331_cal.xml Edgar Link unprocessable
cybe-20200331_def.xml Edgar Link unprocessable
cybe-20200331_htm.xml Edgar Link completed
cybe-20200331_lab.xml Edgar Link unprocessable
cybe-20200331_pre.xml Edgar Link unprocessable
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex32_3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending